American Journal of Obstetrics & Gynecology
Volume 201, Issue 4 , Pages 354.e1-354.e7 , October 2009

Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial

Presented at the 9th Annual Women's Health Research Conference, Chapel Hill, NC, April 1-2, 2008.

  • Geeta K. Swamy, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprints: Geeta K. Swamy, MD, DUMC Box 3967, Durham, NC 27710
    • ,
  • Jennifer J. Roelands, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC
    • ,
  • Bercedis L. Peterson, PhD

      Affiliations

    • Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC
    • ,
  • Laura J. Fish, PhD

      Affiliations

    • Cancer Prevention, Detection and Control Research Program, Duke Comprehensive Cancer Center, Durham, NC
    • ,
  • Cheryl A. Oncken, MD

      Affiliations

    • Department of Medicine, University of Connecticut Health Center, Farmington, CT
    • ,
  • Pamela K. Pletsch, PhD, RN

      Affiliations

    • School of Nursing, University of Wisconsin, Madison, WI
    • ,
  • Evan R. Myers, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC
    • Cancer Prevention, Detection and Control Research Program, Duke Comprehensive Cancer Center, Durham, NC
    • ,
  • Paul W. Whitecar, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Womack Army Medical Center, Fayetteville, NC
    • ,
  • Kathryn I. Pollak, PhD

      Affiliations

    • Department of Community and Family Medicine, Duke University Medical Center, Durham, NC
    • Cancer Prevention, Detection and Control Research Program, Duke Comprehensive Cancer Center, Durham, NC

Received 29 October 2008 ,Revised 10 March 2009 ,Accepted 1 June 2009.

References 

  1. Chapin J, Root W. American College of Obstetricians and Gynecologists (Improving obstetrician-gynecologist implementation of smoking cessation guidelines for pregnant women: an interim report of the American College of Obstetricians and Gynecologists). Nicotine Tob Res. 2004;6(suppl):S253–S257
  2. Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML. Effects of smoking during pregnancy: five meta-analyses. Am J Prev Med. 1999;16:208–215
  3. American College of Obstetricians and Gynecology. ACOG Committee Opinion No.: 316: smoking cessation during pregnancy. Obstet Gynecol. 2005;106:883–888
  4. Salihu HM, Aliyu MH, Pierre-Louis BJ, Alexander GR. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J. 2003;7:219–227
  5. Ventura SJ, Hamilton BE, Mathews TJ, Chandra A. Trends and variations in smoking during pregnancy and low birth weight: evidence from the birth certificate, 1990-2000. Pediatrics. 2003;111:1176–1180
  6. Centers for Disease Control and Prevention. Smoking during pregnancy: United States, 1990-2002. MMWR Morb Mortal Wkly Rep. 2004;53:911–915
  7. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;3:CD000146
  8. Colman GJ, Joyce T. Trends in smoking before, during, and after pregnancy in ten states. Am J Prev Med. 2003;24:29–35
  9. Ogburn PL, Hurt RD, Croghan IT, et al. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 1999;181:736–743
  10. Oncken CA, Hardardottir H, Hatsukami DK, Lupo VR, Rodis JF, Smeltzer JS. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol. 1997;90:569–574
  11. Oncken CA, Hatsukami DK, Lupo VR, Lando HA, Gibeau LM, Hansen RJ. Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther. 1996;59:654–661
  12. Wright LN, Thorp JM, Kuller JA, Shrewsbury RP, Ananth C, Hartmann K. Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol. 1997;176:1090–1094
  13. Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol Teratol. 2008;30:1–19
  14. Hegaard HK, Kjaegaard H, Møller LF, Wachmann H, Ottesen B. Multimodal intervention raises smoking cessation rate during pregnancy. Acta Obstet Gynecol Scand. 2003;82:813–819
  15. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav. 2006;31:641–648
  16. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol. 2000;96:967–971
  17. Pollak KI, Oncken CA, Lipkus IM, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med. 2007;33:297–305
  18. Women and smoking: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001;
  19. Escobedo LG, Reddy M, DuRant RH. Relationship between cigarette smoking and health risk and problem behaviors among US adolescents. Arch Pediatr Adolesc Med. 1997;151:66–71
  20. Lee DJ, Mendes de Leon CF, Markides KS. The relationship between hostility, smoking, and alcohol consumption in Mexican Americans. Int J Addict. 1988;23:887–896
  21. Pierce JP, Farkas A, Evans N, et al. Tobacco use in California 1992: a focus on preventing uptake in adolescents. Sacramento, CA: California Department of Health Services; 1993;
  22. Waldron I. Patterns and causes of gender differences in smoking. Soc Sci Med. 1991;32:989–1005
  23. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed adequacy of prenatal care utilization index. Am J Public Health. 1994;84:1414–1420
  24. Fava JL, Ruggiero L, Grimley DM. The development and structural confirmation of the Rhode Island Stress and Coping Inventory. J Behav Med. 1998;21:601–611
  25. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psycholog Measure. 1977;1:385–401
  26. Harrell FE. Regression modelling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001;
  27. Iams JD, Goldenberg RL, Mercer BM, et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1998;178:1035–1040
  28. Schempf AH, Branham AM, Lukacs AL, Shoendorf KC. The contribution of preterm birth to the black-white infant mortality gap, 1990 and 2000. Am J Public Health. 2007;97:1255–1260
  29. Oncken C, Dornelas E, Greene J, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol. 2008;112:859–867
  30. Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ. 2006;332:937–939
  31. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, et al. Births: final data for 2004. Hyattsville, MD: National Center for Health Statistics; 2006;
  32. Coleman T, Thornton J, Britton J, et al. Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Serv Res. 2007;7:2

 This work was supported by National Cancer Institute Grant R01CA089053 and Duke General Clinical Research Center Protocol 906, M01-RR-30, and operated under IND #67,259, Clinical Trials Registration NCT00224419.

 The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of Defense.

 Cite this article as: Swamy GK, Roelands JJ, Peterson BL, et al. Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. Am J Obstet Gynecol 2009;201:354.e1-7.

PII: S0002-9378(09)00626-7

doi: 10.1016/j.ajog.2009.06.006

American Journal of Obstetrics & Gynecology
Volume 201, Issue 4 , Pages 354.e1-354.e7 , October 2009

Article Tools